Previous 10 | Next 10 |
Advanced Energy Sales increase 58% year-over-year in Q4 and increase 73% year-over-year in FY'19 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvio...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Apyx Medical Corporation (NasdaqGS: APYX). On December 21, 2018, the Company announced th...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced...
InMode (INMD), an Israeli aesthetic medtech company, has developed and commercialized a broad portfolio of proprietary designed Radio Frequency ((RF)) instruments. INMD derives 80% of its revenue in the US and attributes its strength to the following: Technology that kills fat and tightens...
Editor's note: Seeking Alpha is proud to welcome Marvl Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » CellFX, a Pulse Bi...
Advanced Energy Sales of approximately $6.6 to $6.9 million in Q4, up 52% to 58% year-over-year Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion...
Apyx Medical Corporation , formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and as J-Plasma ® ...
Image source: The Motley Fool. Apyx Medical Corp (NASDAQ: APYX) Q3 2019 Earnings Call Nov 11, 2019 , 4:30 p.m. ET Operator Continue reading
Apyx Medical Corporation (APYX) Q3 2019 Earnings Conference Call November 11, 2019 4:30 PM ET Company Participants Charlie Goodwin - President & Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Lucas Baranowski - Craig-Hallum Capita...
News, Short Squeeze, Breakout and More Instantly...
Apyx Medical Corporation Company Name:
APYX Stock Symbol:
NASDAQ Market:
Apyx Medical Corporation Website:
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion ® , today announced that financial results for the second quarter of fiscal year 2024 will be relea...
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health PR Newswire Renuvion is the only device FDA-cleared for contracting subcutaneous tissue CLEARWATER, Fla. ...